(MedPage Today) -- Despite being called a "willful infringer" of patents held by Edwards Lifesciences, Medtronic will be allowed to continue selling its CoreValve transcatheter aortic valve as legal wrangling continues.
(MedPage Today) -- Where do neurostimulators belong in the treatment of headaches? Three well-known specialists said the approved devices appear safe and effective, while research is still ongoing with more invasive approaches that hold promise for currently intractable headaches.
(MedPage Today) -- Psychological effects of false-positive mammograms, an association between trisomy-21 and malignancy, and favorable results from an ovarian cancer trial have all made news recently.
(MedPage Today) -- An FDA advisory committee has voted unanimously against approval of an oral combination of morphine and oxycodone (Moxduo) for acute pain.
(MedPage Today) -- Patients with unruptured arteriovenous malformations (AVMs) in the brain appeared to fare better over the long term by following a conservative strategy and avoiding interventions, a nonrandomized, observational study suggested.
(MedPage Today) -- Diazepam proved equal to lorazepam for effectiveness and safety in treating children with status epilepticus, surprising the randomized trial's investigators and others in the field.
(MedPage Today) -- The new oral anticoagulants, or NOACs -- dabigatran (Pradaxa), rivaroxaban (Xarelto), and Eliquis (apixaban) -- are touted for their safety, efficacy, and ease of use, but they have one drawback in common: There is no antidote.
WASHINGTON (MedPage Today) -- Female physicians made about half as much from Medicare as male doctors did in 2012, according to an analysis of newly released Medicare pay data.
(MedPage Today) -- A drug widely used for a rare neurological condition that mainly affects overweight women -- pseudotumor cerebri -- has successfully passed its first randomized trial, researchers reported.
SAN DIEGO (MedPage Today) -- Building the bridges of generalism with other organizations interested in improving primary care -- especially to vulnerable or complex patients -- will be a major theme at this year's Society of General Internal Medicine meeting.